Tag: stages

EWTN Acquires Holy Habits, a Catholic App Helping Users Build Virtue Through Daily Practice

IRONDALE, Ala., June 10, 2026 /PRNewswire/ -- EWTN Global Catholic Network announced today the acquisition of a majority stake in Holy Habits, a Catholic...

Luxury meets legacy: ORO Hotel & Residences partners with Ron del Barrilito to create Signature Barrilito Bar

The bar will be one of many amenities at the condo-residence hotel that will redefine luxury living in the heart of San Juan’s Financial District

The bar will be one of many amenities at the condo-residence hotel that will redefine luxury living in the heart of San Juan’s Financial District

NOVOSENSE Highlights Latest IC Advancements Across Automotive, White Goods, Industrial Control, and AI Data Center Power at PCIM Europe 2026

NUREMBERG, Germany, June 10, 2026 /PRNewswire/ -- NOVOSENSE Microelectronics (SSE: 688052 | HKEX: 02676) is exhibiting at PCIM Europe 2026, held from June 9...

Antengene Receives IND Approval for ATG-201 (CD19 × CD3 TCE) in Autoimmune Disease in China

SHANGHAI and HONG KONG, June 10, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to...

Medmovie Launches HxHeart.com, Bringing Its Trusted Cardiovascular Education Library to Any Browser — and Releases a New Video on the Hidden Risks of Coronary...

The same clinician-approved animations from the Hx Heart app are now available online at HxHeart.com — free, instantly, with no download required.BERKELEY, Calif., June...

KENCO STEPS-UP AS ‘OFFICIAL SPONSOR OF STAYING AWAKE’ AS SCHEDULE REVEALS SUMMER MATCH TIMES WILL PUSH EUROPEAN FOOTBALL FANS TO THE LIMIT

Published match timings show Central European fans face 71 late-night kick-offs (68.3% of the tournament).UK fans face 60 late-night matches (57.7%), while Eastern European...

10-Person Legacy MEDSearch Named to Forbes America’s Best Executive / Professional Recruiting Firms for the Tenth Time

The Only Exclusively MedTech Firm Among the Top 175 of 22,000+ US Recruiting Firms.ORLANDO, Fla., June 9, 2026 /PRNewswire/ -- For the tenth time...

American Fusion Inc. (OTC: AMFN) Provides Development and Testing Update for 5MW Pre-Production Texatron™ Fusion Engine™

American Fusion Provides Development and Testing Update for 5MW Pre-Production Texatron™ Fusion Engine™

P2 Gold Gabbs Project Update: Feasibility Study on Track

VANCOUVER, BC, June 9, 2026 /CNW/ - P2 Gold Inc. ("P2" or the "Company") (TSXV: PGLD) (OTCQB: PGLDF) provides an update on the activities underway...

Think Digital, a Division of Think Education, Launches Raly Report to Streamline LCAP Development for California Education Leaders

AI-powered platform reduces administrative resources and helps leaders focus on student outcomesSANTA ANA, Calif., June 8, 2026 /PRNewswire/ -- Think Digital, a division of...

Ascendis to Showcase Advances in Treatment of Rare Endocrine Diseases at ENDO 2026

COPENHAGEN, Denmark, June 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its Endocrinology Rare Disease programs in hypoparathyroidism, achondroplasia, and pediatric growth hormone deficiency will be shared in two oral presentations and three posters at ENDO 2026, the annual meeting of the Endocrine Society being held in Chicago from June 13-16, 2026.

D1 Training Named a Top 10 Fitness Franchise in Entrepreneur’s New 2026 Industry Rankings

Athletic-Based Training Brand Earns No. 10 Spot Among the Nation's Leading Fitness Franchises in Entrepreneur's Inaugural Industry-Specific RankingNASHVILLE, Tenn., June 8, 2026 /PRNewswire/ --...

Helius Minerals Provides Status Update on Serra Pelada Project Acquisition Transaction

VANCOUVER, BC, June 8, 2026 /CNW/ - Helius Minerals Limited ("Helius" or the "Company") (TSXV: HHH) is pleased to provide an update on the status...

Foresee’s Oral ALDH2 Activator, Mirivadelgat to Enter Clinical Testing in Parkinson’s Disease in the SLEIPNIR Phase 2a Platform Trial

TAIPEI, June 8, 2026 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced today that Foresee's oral ALDH2 activator, mirivadelgat, has been selected to enter clinical testing in...

STATEMENT – Feds prioritize kids over big tech profits: CMA

Canada Nickel Completes Upsized Non-Brokered Private Placement of Flow-Through Shares and Provides Corporate Update

SIR Royalty Income Fund Announces June 2026 Distribution